000403 派林生物
已收盘 08-05 15:00:00
资讯
新帖
简况
股市必读：派林生物新发布《关于回购公司股份的进展公告》
证券之星 · 03:13
股市必读：派林生物新发布《关于回购公司股份的进展公告》
派林生物（000403）披露回购公司股份进展公告，8月3日股价上涨1.82%
证券之星 · 08-03 22:44
派林生物（000403）披露回购公司股份进展公告，8月3日股价上涨1.82%
每周股票复盘：派林生物（000403）同智成科技质押4763万股占总股本5.01%
证券之星 · 07-26
每周股票复盘：派林生物（000403）同智成科技质押4763万股占总股本5.01%
派林生物（000403）披露股东股份解除质押及重新质押公告，7月24日股价下跌2.68%
证券之星 · 07-24
派林生物（000403）披露股东股份解除质押及重新质押公告，7月24日股价下跌2.68%
每周股票复盘：派林生物（000403）Q2净利预降超53%
证券之星 · 07-19
每周股票复盘：派林生物（000403）Q2净利预降超53%
派林生物（000403）披露股东股份质押公告，7月14日股价上涨0.65%
证券之星 · 07-14
派林生物（000403）披露股东股份质押公告，7月14日股价上涨0.65%
派林生物：预计2026年1-6月每股收益盈利:0.08元至0.12元
证券之星 · 07-14
派林生物：预计2026年1-6月每股收益盈利:0.08元至0.12元
派林生物：公司截止2026年7月10日股东人数36741户
证券之星 · 07-14
派林生物：公司截止2026年7月10日股东人数36741户
每周股票复盘：派林生物（000403）回购股份1.11%
证券之星 · 07-05
每周股票复盘：派林生物（000403）回购股份1.11%
派林生物（000403）披露回购公司股份进展公告，7月1日股价上涨3.41%
证券之星 · 07-01
派林生物（000403）披露回购公司股份进展公告，7月1日股价上涨3.41%
股市必读：派林生物（000403）6月26日收盘跌5.14%，主力净流出1515.01万元
证券之星 · 06-29
股市必读：派林生物（000403）6月26日收盘跌5.14%，主力净流出1515.01万元
每周股票复盘：派林生物（000403）股东户数降2.63%
证券之星 · 06-28
每周股票复盘：派林生物（000403）股东户数降2.63%
派林生物（000403）披露回购公司股份比例达到1%的进展公告，6月26日股价下跌5.14%
证券之星 · 06-26
派林生物（000403）披露回购公司股份比例达到1%的进展公告，6月26日股价下跌5.14%
派林生物：公司下属两家子公司广东双林和派斯菲科二期产能扩增已于2025年完成并顺利投产
证券日报 · 06-24
派林生物：公司下属两家子公司广东双林和派斯菲科二期产能扩增已于2025年完成并顺利投产
派林生物(000403)6月18日股东户数3.67万户，较上期减少2.63%
证券之星 · 06-24
派林生物(000403)6月18日股东户数3.67万户，较上期减少2.63%
派林生物：公司2026年2季度生产及批签发均按计划正常开展
证券之星 · 06-24
派林生物：公司2026年2季度生产及批签发均按计划正常开展
6月22日派林生物（000403）龙虎榜数据：机构净卖出2578.92万元，北向资金净卖出69.24万元
证券之星 · 06-22
6月22日派林生物（000403）龙虎榜数据：机构净卖出2578.92万元，北向资金净卖出69.24万元
异动快报：派林生物（000403）6月22日13点27分触及跌停板
证券之星 · 06-22
异动快报：派林生物（000403）6月22日13点27分触及跌停板
国药系终止47亿并购，抽身派林生物
市场资讯 · 06-21
国药系终止47亿并购，抽身派林生物
每周股票复盘：派林生物（000403）股东户数减少2.51%，户均持股市值30.06万元
证券之星 · 06-14
每周股票复盘：派林生物（000403）股东户数减少2.51%，户均持股市值30.06万元
加载更多
公司概况
公司名称：
派斯双林生物制药股份有限公司
所属行业：
医药制造业
上市日期：
1996-06-28
主营业务：
派斯双林生物制药股份有限公司的主营业务是血液制品的研究、开发、生产和销售。公司的主要产品是人血白蛋白、静注人免疫球蛋白(pH4)、人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白、狂犬病人免疫球蛋白、人凝血因子Ⅷ、人凝血酶原复合物。
发行价格：
3.78
{"stockData":{"symbol":"000403","market":"SZ","secType":"STK","nameCN":"派林生物","latestPrice":10.5,"timestamp":1785913395000,"preClose":10.5,"halted":0,"volume":8678834,"delay":0,"changeRate":0,"floatShares":941000000,"shares":950000000,"eps":0.3716,"marketStatus":"已收盘","change":0,"latestTime":"08-05 15:00:00","open":10.48,"high":10.58,"low":10.36,"amount":90821300,"amplitude":0.021,"askPrice":10.52,"askSize":25,"bidPrice":10.5,"bidSize":326,"shortable":0,"etf":0,"ttmEps":0.3716,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785979800000},"marketStatusCode":5,"adr":0,"adjPreClose":10.5,"symbolType":"stock","openAndCloseTimeList":[[1785893400000,1785900600000],[1785906000000,1785913200000]],"highLimit":11.55,"lowLimit":9.45,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":950397386,"isCdr":false,"pbRate":1.23,"roa":"--","peRate":28.256189,"roe":"0.28%","epsLYR":0.44,"committee":-0.166535,"marketValue":9979000000,"turnoverRate":0.0092,"status":2,"floatMarketCap":9877000000},"requestUrl":"/m/hq/s/000403/","defaultTab":"news","newsList":[{"id":"2657565738","title":"股市必读：派林生物新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2657565738?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:13","pubTimestamp":1785870790,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年7月31日，派林生物已回购股份12,423,491股，占总股本1.31%，成交总金额1.3387亿元，回购进展符合方案及法规要求。公司公告汇总关于回购公司股份的进展公告派斯双林生物制药股份有限公司于2026年4月27日召开董事会，审议通过以集中竞价方式回购股份的议案。公司拟使用自有或自筹资金不低于20,000万元且不超过30,000万元，以不超过19.50元/股的价格回购A股股份，回购期限为董事会审议通过之日起12个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656770273","title":"派林生物（000403）披露回购公司股份进展公告，8月3日股价上涨1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656770273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2656770273?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:44","pubTimestamp":1785768256,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，派林生物报收于10.62元，较前一交易日上涨1.82%，最新总市值为100.93亿元。近日，派林生物披露《关于回购公司股份的进展公告》。公告显示，公司于2026年4月27日召开董事会，审议通过以集中竞价方式回购股份的议案。公司拟使用自有或自筹资金不低于20,000万元且不超过30,000万元，以不超过19.50元/股的价格回购A股股份，回购期限为董事会审议通过之日起12个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654505750","title":"每周股票复盘：派林生物（000403）同智成科技质押4763万股占总股本5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654505750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654505750?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:24","pubTimestamp":1785003853,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：同智成科技累计质押股份47,630,000股，占其所持股份比例为45.58%，占公司总股本比例为5.01%公司公告汇总派斯双林生物制药股份有限公司股东哈尔滨同智成科技开发有限公司将其持有的26,000,000股股份解除质押，并将31,800,000股股份重新质押给中国银河证券股份有限公司，用于补充流动资金。本次解除质押及重新质押后，同智成科技累计质押股份为47,630,000股，占其所持股份比例为45.58%，占公司总股本比例为5.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653338840","title":"派林生物（000403）披露股东股份解除质押及重新质押公告，7月24日股价下跌2.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653338840","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653338840?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:30","pubTimestamp":1784903440,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，派林生物报收于9.44元，较前一交易日下跌2.68%，最新总市值为89.72亿元。近日，派林生物披露《关于公司股东股份解除质押及重新质押的公告》。公告显示，公司股东哈尔滨同智成科技开发有限公司将其持有的26,000,000股股份解除质押，并将31,800,000股股份重新质押给中国银河证券股份有限公司，用于补充流动资金。本次解除质押及重新质押后，同智成科技累计质押股份为47,630,000股，占其所持股份比例为45.58%，占公司总股本比例为5.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652303142","title":"每周股票复盘：派林生物（000403）Q2净利预降超53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652303142","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652303142?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:21","pubTimestamp":1784398868,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，派林生物报收于9.73元，较上周的9.22元上涨5.53%。公司公告汇总：股东同智成科技质押1583万股，占公司总股本1.67%，累计质押比例达40.03%。股本股东变化截至2026年7月10日，派林生物股东户数为3.67万户，较6月30日减少154.0户，减幅0.42%。本次质押后累计质押股份为41,830,000股，占其所持股份比例40.03%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0071","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651102843","title":"派林生物（000403）披露股东股份质押公告，7月14日股价上涨0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651102843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651102843?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:40","pubTimestamp":1784040022,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，派林生物报收于9.27元，较前一交易日上涨0.65%，最新总市值为88.1亿元。该股当日开盘9.12元，最高9.44元，最低9.12元，成交额达1.04亿元，换手率为1.19%。近日，派林生物披露《关于公司股东股份质押的公告》。本次质押股份不存在重大资产重组等业绩补偿义务。本次质押后，同智成科技累计质押股份为41,830,000股，占其所持股份比例40.03%。公司表示，股东具备良好资金偿还能力，质押股份无平仓风险，不影响公司经营管理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651310302","title":"派林生物：预计2026年1-6月每股收益盈利:0.08元至0.12元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651310302","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651310302?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:13","pubTimestamp":1784031213,"startTime":"0","endTime":"0","summary":"证券之星消息，派林生物发布业绩预告，预计2026年1-6月每股收益盈利:0.08元至0.12元。派林生物2026年一季报显示，一季度公司主营收入3.43亿元，同比下降8.47%；归母净利润2296.88万元，同比下降74.22%；扣非净利润1297.84万元，同比下降83.03%；负债率13.63%，投资收益302.42万元，财务费用-753.62万元，毛利率34.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400044570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651022127","title":"派林生物：公司截止2026年7月10日股东人数36741户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651022127","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651022127?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:07","pubTimestamp":1784012835,"startTime":"0","endTime":"0","summary":"证券之星消息，派林生物(000403)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司截止2026.07.10日的最新股东人数是多少人？谢谢派林生物回复：尊敬的投资者，您好！公司截止2026年7月10日股东人数36741户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400022727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692352","title":"每周股票复盘：派林生物（000403）回购股份1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649692352?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:27","pubTimestamp":1783193230,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，派林生物报收于9.29元，较上周的8.86元上涨4.85%。关于回购公司股份的进展公告：截至2026年6月30日，公司已回购股份10,551,791股，占总股本1.11%。关于回购公司股份的进展公告派斯双林生物制药股份有限公司于2026年4月27日召开董事会，审议通过以集中竞价方式回购股份的议案，拟使用自有或自筹资金20,000万元至30,000万元回购A股股票，回购价格不超19.50元/股，回购期限为董事会审议通过之日起12个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648519544","title":"派林生物（000403）披露回购公司股份进展公告，7月1日股价上涨3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648519544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648519544?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:59","pubTimestamp":1782917950,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，派林生物报收于9.09元，较前一交易日上涨3.41%，最新总市值为86.39亿元。该股当日开盘8.79元，最高9.16元，最低8.65元，成交额达1.43亿元，换手率为1.69%。近日，派林生物发布《关于回购公司股份的进展公告》。本次回购符合既定方案及相关法规要求。公司后续将根据市场情况继续实施回购，并及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343382","title":"股市必读：派林生物（000403）6月26日收盘跌5.14%，主力净流出1515.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647343382?lang=zh_cn&edition=full","pubTime":"2026-06-29 02:47","pubTimestamp":1782672431,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，派林生物报收于8.86元，下跌5.14%，换手率1.48%，成交量13.92万手，成交额1.25亿元。公司公告汇总：截至6月25日，公司已回购股份10,551,791股，占总股本1.11%，成交总金额115,975,113.73元，回购比例已达1%。交易信息汇总股价提醒6月26日派林生物收盘报8.86元，跌5.14%，当日成交1.25亿元。前10个交易日主力资金累计净流出1.48亿元，股价累计下跌5.14%；融资余额累计减少1823.1万元，融券余量累计减少7900股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900000858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313130","title":"每周股票复盘：派林生物（000403）股东户数降2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646313130?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:28","pubTimestamp":1782584892,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，派林生物报收于8.86元，较上周的10.81元下跌18.04%。股本股东变化股东户数变动近日派林生物披露，截至2026年6月18日公司股东户数为3.67万户，较6月10日减少992.0户，减幅为2.63%。公司公告汇总股票交易异常波动公告派斯双林生物制药股份有限公司股票连续三个交易日收盘价格跌幅偏离值累计超过20%，构成股票交易异常波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000611.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646135511","title":"派林生物（000403）披露回购公司股份比例达到1%的进展公告，6月26日股价下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646135511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646135511?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:51","pubTimestamp":1782467491,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，派林生物报收于8.86元，较前一交易日下跌5.14%，最新总市值为84.21亿元。该股当日开盘9.3元，最高9.3元，最低8.86元，成交额达1.25亿元，换手率为1.48%。近日，派林生物披露《关于回购公司股份比例达到1%的进展公告》。本次回购符合既定方案及相关法律法规要求。公司后续将根据市场情况继续实施回购计划，并按规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645819417","title":"派林生物：公司下属两家子公司广东双林和派斯菲科二期产能扩增已于2025年完成并顺利投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819417","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645819417?lang=zh_cn&edition=full","pubTime":"2026-06-24 21:54","pubTimestamp":1782309240,"startTime":"0","endTime":"0","summary":"证券日报网讯 6月24日，派林生物在互动平台回答投资者提问时表示，公司下属两家子公司广东双林和派斯菲科二期产能扩增已于2025年完成并顺利投产，公司2026年2季度生产及批签发均按计划正常开展，各项经营管理工作有序推进。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-24/doc-iniepqxq6085239.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-24/doc-iniepqxq6085239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645996138","title":"派林生物(000403)6月18日股东户数3.67万户，较上期减少2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645996138","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645996138?lang=zh_cn&edition=full","pubTime":"2026-06-24 17:35","pubTimestamp":1782293750,"startTime":"0","endTime":"0","summary":"证券之星消息，近日派林生物披露，截至2026年6月18日公司股东户数为3.67万户，较6月10日减少992.0户，减幅为2.63%。在生物制品行业个股中，派林生物股东户数高于行业平均水平，截至6月18日，生物制品行业平均股东户数为3.56万户。根据统计，派林生物2026年6月10日至2026年6月18日，主力资金净流出7254.47万元，游资资金净流入3548.94万元，散户资金净流入3705.52万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400032279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0071","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645766867","title":"派林生物：公司2026年2季度生产及批签发均按计划正常开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2645766867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645766867?lang=zh_cn&edition=full","pubTime":"2026-06-24 15:00","pubTimestamp":1782284446,"startTime":"0","endTime":"0","summary":"证券之星消息，派林生物(000403)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司四月份五月份产能利用率派林生物回复：尊敬的投资者，您好！公司下属两家子公司广东双林和派斯菲科二期产能扩增已于2025年完成并顺利投产，公司2026年2季度生产及批签发均按计划正常开展，各项经营管理工作有序推进。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400022086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645023101","title":"6月22日派林生物（000403）龙虎榜数据：机构净卖出2578.92万元，北向资金净卖出69.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645023101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645023101?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:43","pubTimestamp":1782121431,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年6月22日公布的交易公开信息显示，派林生物因日跌幅偏离值达到7%的前5只证券，连续三个交易日内，跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年6月22日收盘，派林生物报收于9.73元，下跌9.99%，跌停，换手率3.5%，成交量32.93万手，成交额3.25亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出2578.92万元，北向资金合计净卖出69.24万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200026470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645045085","title":"异动快报：派林生物（000403）6月22日13点27分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2645045085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645045085?lang=zh_cn&edition=full","pubTime":"2026-06-22 13:30","pubTimestamp":1782106253,"startTime":"0","endTime":"0","summary":"证券之星6月22日盘中消息，13点27分派林生物（000403）触及跌停板。其所属行业生物制品目前下跌。领涨股为欧林生物。该股为血制品概念热股。6月18日的资金流向数据方面，主力资金净流出2699.72万元，占总成交额7.23%，游资资金净流入745.76万元，占总成交额2.0%，散户资金净流入1953.96万元，占总成交额5.23%。近5日资金流向一览见下表：派林生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200015347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0071","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645948300","title":"国药系终止47亿并购，抽身派林生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2645948300","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645948300?lang=zh_cn&edition=full","pubTime":"2026-06-21 10:00","pubTimestamp":1782007200,"startTime":"0","endTime":"0","summary":" 直击大健康行业动态与药企财报，一线政策解读，迅速看懂医药前景。 赶在端午节前，国药系终止一笔重磅大交易。 6月，派林生物宣告持续近一年的重磅控制权转让交易正式落幕。 根据公告，国药集团旗下中国生物与控股股东胜帮英豪达成一致，终止作价46.99亿元的股份转让协议。2025年，派林生物停牌披露控制权变更计划，陕西国资平台拟出让21.03%股份，一旦完成过户，中国生物将成为派林生物控股股东，国药集团同步取得实控权。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-06-21/doc-iniecryy1212715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0071","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643172542","title":"每周股票复盘：派林生物（000403）股东户数减少2.51%，户均持股市值30.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643172542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643172542?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:40","pubTimestamp":1781372424,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，派林生物报收于11.88元，较上周的12.73元下跌6.68%。本周，派林生物6月8日盘中最高价报12.65元。本周关注点股本股东变化：股东户数较上期减少2.51%，户均持股市值为30.06万元股本股东变化股东户数变动截至2026年6月10日，公司股东户数为3.77万户，较5月8日减少969.0户，减幅为2.51%。户均持股数量由上期的2.46万股上升至2.52万股，户均持股市值为30.06万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785938569042,"stockEarnings":[{"period":"1week","weight":0.0553},{"period":"1month","weight":0.1302},{"period":"3month","weight":-0.1033},{"period":"6month","weight":-0.2313},{"period":"1year","weight":-0.4318},{"period":"ytd","weight":-0.233}],"compareEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":-0.0547},{"period":"3month","weight":-0.0812},{"period":"6month","weight":-0.0622},{"period":"1year","weight":0.0667},{"period":"ytd","weight":-0.0369}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"派斯双林生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36741人(较上一季度减少0.42%)","perCapita":"25603股","listingDate":"1996-06-28","address":"山西省太原市晋源区长兴南街8号阳光城环球金融中心3004室","registeredCapital":"95039万元","survey":" 派斯双林生物制药股份有限公司的主营业务是血液制品的研究、开发、生产和销售。公司的主要产品是人血白蛋白、静注人免疫球蛋白(pH4)、人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白、狂犬病人免疫球蛋白、人凝血因子Ⅷ、人凝血酶原复合物。","listedPrice":3.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"派林生物(000403)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供派林生物(000403)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"派林生物,000403,派林生物股票,派林生物股票老虎,派林生物股票老虎国际,派林生物行情,派林生物股票行情,派林生物股价,派林生物股市,派林生物股票价格,派林生物股票交易,派林生物股票购买,派林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"派林生物(000403)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供派林生物(000403)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}